Evidence map›Paper›PMID 16235064›Full record

ArticleNeurogenetics2006

Screening of ARX in mental retardation families: Consequences for the strategy of molecular diagnosis.

K Poirier, D Lacombe, B Gilbert-Dussardier, M Raynaud, V Desportes, A P M de Brouwer, C Moraine, J P Fryns, H H Ropers, C Beldjord and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Cellular Functional Analyses ofHuman mutation · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Basal ganglia involvement inNeuroImage. Clinical · 2018
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Drosophila PQBP1 regulates learning acquisition at projection neurons in aversive olfactory conditioning.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  15. Article
  16. Article
  17. Article
  18. Mutation screening of the ARX gene in patients with autism.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2007
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

K PoirierUniversité Paris Descartes, Faculté de Medicine René Descarte, UMR-S 8104, Paris, F-75014 France.
D Lacombe
B Gilbert-Dussardier
M Raynaud
V Desportes
A P M de Brouwer
C Moraine
J P Fryns
H H Ropers
C Beldjord
J Chelly
T Bienvenu
Hôpital Cochin · FRInserm · FRHôpital Dupuytren · FRHôpital Lyon Sud · FRHôpital Pellegrin · FRInstitut Cochin · FRMax Planck Institute for Molecular Genetics · DEUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the human ARX gene have been shown to cause nonsyndromic X-linked mental retardation (MRX) as well as syndromic forms such as X-linked lissencephaly with abnormal genitalia (XLAG), Partington syndrome and X-linked infantile spasm. The most common causative mutation, a duplication of 24 bp, was found in families with a variety of phenotypes, but not in the more severe XLAG phenotypes. The aim of the study was to access the frequency of ARX mutations in families with established or putative X-linked mental retardation (XLMR) collected by the European XLMR Consortium. We screened the entire coding region of ARX for mutations in 197 novel XLMR families by denaturing high-performance liquid chromatography, and we identified eight mutations (six c.428_451dup24, one insertion and one novel missense mutation p.P38S). To better define the prevalence of ARX mutations, we included previously reported results of 157 XLMR families. Together, these data showed the relatively high rate (9.5%) of ARX mutations in X-linked MR families and an expectedly low rate in families with affected brother pairs (2.2%). This study confirms that the frequency of ARX mutations is high in XLMR, and the analysis of ARX in MRX should not be limited to duplication.

Indexed as

Genetic TestingX-Linked Intellectual DisabilityAmino Acid SequenceAnimalsDNA Mutational AnalysisFemaleHomeodomain ProteinsHumansMaleMolecular Diagnostic TechniquesMolecular Sequence DataMutationPedigreeSyndromeTranscription FactorsARX protein, humanHomeodomain ProteinsTranscription Factors

Identifiers

PMID16235064
OpenAlexW2120042633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.